Cargando…

Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic

Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, data registered in the European countries revealed increasing cases of infection in cystic fibrosis (CF) patients. In the course of this pandemic, we enrolled 17 CF patients for a study evaluating infla...

Descripción completa

Detalles Bibliográficos
Autores principales: Baresi, Giulia, Giacomelli, Mauro, Moratto, Daniele, Chiarini, Marco, Conforti, Immacolata Claudia, Padoan, Rita, Poli, Piercarlo, Timpano, Silviana, Caldarale, Francesca, Badolato, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291286/
https://www.ncbi.nlm.nih.gov/pubmed/34295857
http://dx.doi.org/10.3389/fped.2021.645063
_version_ 1783724607950290944
author Baresi, Giulia
Giacomelli, Mauro
Moratto, Daniele
Chiarini, Marco
Conforti, Immacolata Claudia
Padoan, Rita
Poli, Piercarlo
Timpano, Silviana
Caldarale, Francesca
Badolato, Raffaele
author_facet Baresi, Giulia
Giacomelli, Mauro
Moratto, Daniele
Chiarini, Marco
Conforti, Immacolata Claudia
Padoan, Rita
Poli, Piercarlo
Timpano, Silviana
Caldarale, Francesca
Badolato, Raffaele
author_sort Baresi, Giulia
collection PubMed
description Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, data registered in the European countries revealed increasing cases of infection in cystic fibrosis (CF) patients. In the course of this pandemic, we enrolled 17 CF patients for a study evaluating inflammatory markers. One of them developed COVID-19, giving us the possibility to analyze inflammatory markers in the acute phase as compared to levels detected before and after the infectious episode and to levels measured in the other CF patients enrolled to the study who did not experience COVID-19 and 23 patients referred to our center for SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-8291286
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82912862021-07-21 Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic Baresi, Giulia Giacomelli, Mauro Moratto, Daniele Chiarini, Marco Conforti, Immacolata Claudia Padoan, Rita Poli, Piercarlo Timpano, Silviana Caldarale, Francesca Badolato, Raffaele Front Pediatr Pediatrics Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, data registered in the European countries revealed increasing cases of infection in cystic fibrosis (CF) patients. In the course of this pandemic, we enrolled 17 CF patients for a study evaluating inflammatory markers. One of them developed COVID-19, giving us the possibility to analyze inflammatory markers in the acute phase as compared to levels detected before and after the infectious episode and to levels measured in the other CF patients enrolled to the study who did not experience COVID-19 and 23 patients referred to our center for SARS-CoV-2 infection. Frontiers Media S.A. 2021-07-06 /pmc/articles/PMC8291286/ /pubmed/34295857 http://dx.doi.org/10.3389/fped.2021.645063 Text en Copyright © 2021 Baresi, Giacomelli, Moratto, Chiarini, Conforti, Padoan, Poli, Timpano, Caldarale and Badolato. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Baresi, Giulia
Giacomelli, Mauro
Moratto, Daniele
Chiarini, Marco
Conforti, Immacolata Claudia
Padoan, Rita
Poli, Piercarlo
Timpano, Silviana
Caldarale, Francesca
Badolato, Raffaele
Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic
title Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic
title_full Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic
title_fullStr Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic
title_full_unstemmed Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic
title_short Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic
title_sort case report: analysis of inflammatory cytokines il-6, ccl2/mcp1, ccl5/rantes, cxcl9/mig, and cxcl10/ip10 in a cystic fibrosis patient cohort during the first wave of the covid-19 pandemic
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291286/
https://www.ncbi.nlm.nih.gov/pubmed/34295857
http://dx.doi.org/10.3389/fped.2021.645063
work_keys_str_mv AT baresigiulia casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic
AT giacomellimauro casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic
AT morattodaniele casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic
AT chiarinimarco casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic
AT confortiimmacolataclaudia casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic
AT padoanrita casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic
AT polipiercarlo casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic
AT timpanosilviana casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic
AT caldaralefrancesca casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic
AT badolatoraffaele casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic